Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

20.79
Delayed Data
As of May 26
 -0.71 / -3.30%
Today’s Change
11.41
Today|||52-Week Range
24.88
+69.44%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close21.50
Today’s open21.49
Day’s range20.75 - 21.49
Volume1,523,060
Average volume (3 months)1,875,846
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-15.32%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book37.38

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.10-1.38%
EXASExact Sciences Corp+0.13+0.39%
JUNOJuno Therapeutics In...-2.22-8.70%
XONIntrexon Corp-0.22-1.00%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts